Evaluation of Pelvic Floor Muscle Strength in Women With Stress Urinary Incontinence

NCT ID: NCT07320573

Last Updated: 2026-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-02

Study Completion Date

2026-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pelvic floor muscle strength will be measured in women with stress urinary incontinence using superficial EMG, intravaginal EMG, and digital palpation. A 10-minute rest period will be given between each measurement, and the results will be recorded. Once all measurements are completed, any differences between the three measurements will be examined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pelvic floor muscle strength will be assessed by vaginal palpation in the women included in the study. Then, patients will be placed in a hook position for EMG measurement. For superficial measurement, electrodes will be placed on the levator ani muscle on either side, and then the first assessment will be performed in 3 trials consisting of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment in 3 trials consisting of 2 seconds of contraction followed by 5 seconds of rest.

Measurement with an intervaginal electrode will also be performed in the supine hook position, using a passive electrode and an active vaginal probe. Lubricant gel will be applied to the vaginal probe before insertion into the vagina, and the passive electrode will be placed on the inner surface of the right thigh (adductor muscle group). Two different protocols will be used for assessment. The first assessment will consist of 3 trials of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment will consist of 3 trials of 2 seconds of contraction followed by 5 seconds of rest. A 10-minute rest period will be included between measurements. The ICIQ-SF questionnaire will also be used to determine the type and degree of incontinence. Participants will be asked to answer the questions considering the last two weeks. A score will then be assigned.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Floor Muscle Strength Measurement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

stress urinary incontinence

Pelvic floor muscle strength will be measured superficially, intravaginally, and digitally.

Electromyography

Intervention Type DEVICE

Muscle strength values will be obtained using surface electrodes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electromyography

Muscle strength values will be obtained using surface electrodes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over 18 years of age
* Having stress urinary incontinence
* Being willing to participate in the study

Exclusion Criteria

* Unwillingness to continue working
* Presence of a neurological disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ahi Evran University Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esra BAYRAMOĞLU DEMİRDÖĞEN

LecTURER DOCTOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital

Kırşehir, Centre, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ESRA BAYRAMOĞLU DEMİRDÖĞEN, PHD

Role: CONTACT

0542 696 11 69

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KAEU-EBAYRAMOGLUD-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.